The Arkansas Racing Commission approved the entire program Sept. 11. Once implemented, Arkansas will become the sixth state to fully administer the Racing Medication and Testing Consortium's National Uniform Medication rules.
Kentucky regulators are considering allowing tracks in the state to card races that would prohibit the administration of race-day furosemide, commonly called Salix or Lasix.
A 12.5% increase in the minimum riding fee scale for losing jockeys in California got an unexpected addition from the state's horse racing board Aug. 21.
The National Horsemen's Benevolent and Protective Association restated its strong support for the continued use of Lasix (furosemide, also commonly called Salix) at its summer convention Aug.15-17 in Oklahoma City.
In response to a statement from 25 prominent horsemen calling for a ban on the race-day use of furosemide, the Florida Horsemen's Benevolent and Protective Association Aug. 8 issued an open letter opposing changes.
Advocates for change in horse racing didn't find much reason for optimism in the National Thoroughbred Racing Association's legislative update held in Saratoga Springs Aug. 7.
In response to several top trainers calling for the end of race-day furosemide, horsemen's groups throughout the country say they will continue to support the use of the diuretic to prevent or reduce the severity of EIPH.
A revamped racing program and enhancements to the customer experience were among the successes trumpeted by the NYRA board of directors Aug. 6, and in return president Christopher Kay received a bonus and a raise.
Some of North America's top trainers are backing a plan to eliminate the use of race-day medication in the U.S. beginning next season with 2-year-olds, and expanding to all horses in 2016.
A new study finds no difference in the racing career longevity between horses who experience some level of exercise-induced pulmonary hemorrhage and those who never experience EIPH.
Multiple racing jurisdictions have adopted all or parts of the National Uniform Medication Program, with others expected to be on board by the end of this year.
The Jockey Club should push for more in-depth furosemide research. read blog
The Jockey Club has called on leading industry organizations to come together to conduct a Salix study that would examine the timing of administration on the medication used to prevent exercise-induced pulmonary hemorrhage.
Dr. Christopher Riggs, head of veterinary clinic services for The Hong Kong Jockey Club, provides insight into how medication is dispensed and monitored at the HKJC racetracks.
People for the Ethical Treatment of Animals said it will "go away" if horse racing addresses its medication issues, and industry officials who have been trying to do just that suggest progress is evident but not recognized.
Kentucky horsemen March 14 were given an overview of impending equine medication changes and also provided with a few tips to avoid headaches when the new regulations take effect later in the spring.
A Jan. 30 meeting of racing stakeholders in the Mid-Atlantic and Northeast regions showed how difficult it can be to achieve uniformity, even with the best intentions or most basic of regulations.
When is a scientific study not a scientific study? That was a question posed by several panelists during a two-hour session on medication Jan. 25 during the National HBPA winter convention.
Here's a follow-up look at racing statistics of juveniles involved in the furosemide observational study results released Dec. 16 by Breeders' Cup from this year's World Championships and two California-bred stakes.
Study finds 2-year-olds racing without race-day furosemide at 2013 Breeders' Cup World Championships at Santa Anita Park had fewer and less severe EIPH instances than juveniles who raced with the diuretic that weekend at SA.
Breeders' Cup chairman Bill Farish acknowledged the organization's board of directors has some key issues it needs to address, not the least of which is the host-site selection process.
The Maryland Racing Commission Sept. 17 adopted uniform medication and drug-testing rules as part of a push in the Mid-Atlantic region.
Though Breeders' Cup this year will "monitor the performance" of 2-year-olds that must race without furosemide in its World Championships, the therapeutic medication will be available for use in all races for the 2014 event.
Horses competing in the upcoming Breeders' Cup at Santa Anita Park will form a test sample of the potential effects of running without anti-bleeding medications, but it will be up to their owners whether to participate.
An initial introduction in Kentucky of the Mid-Atlantic Uniform Medication Program received raised eyebrows, but supporters of the changes are encouraged that the important racing state is giving the program consideration.
For the second year in a row, many of horse racing's top owners have pledged to race their juvenile starters without race-day medication.
The West Virginia Racing Commission July 23 unanimously approved revised Thoroughbred racing rules, including several amendments that deal with equine medication and drug testing.
Regulatory administration of race-day anti-bleeding medication in Kentucky has provided a clearer picture of drug testing and produced added security benefits, officials said.
The Thoroughbred Owners and Breeders Association announced May 30 that Flair LLC, maker of FLAIR(r) Equine Nasal Strips, has become an official marketing partner of TOBA.
A study conducted at Kentucky Equine Research indicates that 72 hours after being administered Salix (furosemide, also commonly called Lasix), active horses had difficulty replenishing calcium levels.
The Thoroughbred Owners of California will join regulators from eight states in the Mid-Atlantic and Northeast by committing to implement the Mid-Atlantic Uniform Medication Program in January 2014.
The California Horse Racing Board's equine medical director would be restricted to serving no more than two two-year terms consecutively under a state Assembly bill currently before a legislative committee.
Treatment of exercise-induced pulmonary hemorrhage by non-medicinal means was discussed April 9 during a seminar that focused on use of FLAIR Nasal Strips.
Among the speakers for an April 9 seminar on exercise-induced pulmonary hemorrhage are three trainers, officials announced.
- By Tom LaMarra
The horse racing industry is taking a closer look at a relaxant that produces optimum results when administered within a few hours of a race. The prevalence of GABA, a supplement, is open to speculation.
With Breeders' Cup at least slowing implementation of its race-day Salix prohibition, the Kentucky Horse Racing Commission could revisit its plans to ban use of the diuretic on race day.
Just days before the Breeders' Cup board of directors conducted a vote on Salix use at its world championships, prominent owners Gary and Mary West threatened litigation against the organization.
The New York Racing Association said Feb. 27 it is considering changes in racing surfaces and is examining internal procedures it uses for rule violations.
Breeders' Cup will not expand its prohibition of furosemide to additional championship races this year but opted to continue last year's policy of banning the diuretic in juvenile races and allowing it in all others.
The National Horsemen's Benevolent and Protective Association Medication Committee voted Feb. 23 to endorse the use of race-day furosemide, also called Salix or Lasix, at this year's Breeders' Cup World Championships.
The Breeders' Cup Board discussed the scheduled prohibition of race-day furosemide at this year's Breeders' Cup World Championships during a Feb. 22 meeting at Gulfstream Park, but took no action.
Horsemen expect members of Congress to make another attempt at winning support for legislation that would regulate medication use in racehorses by banning all race-day administration.
The Maryland Racing Commission voted Feb. 19 to adopt a uniform equine medication, penalty, and testing program proposed for Thoroughbred and Standardbred racetracks throughout the Mid-Atlantic region.
Members passed a resolution supporting The Jockey Club's Reformed Racing Medication Rules including a two-category medication system, progressive points-style penalties, and reciprocity among jurisdictions.
A group of scientists met with representatives of the Thoroughbred Owners of California Jan. 18 to discuss exercise-induced pulmonary hemorrhaging and later issued a joint statement supporting use of furosemide.
Legislation calling for a ban on performance-enhancing drugs in horse racing has been sent to the New York Senate Racing, Gaming, and Wagering Committee.
Mary Simon won her second Eclipse Award for an article examining the history and current state of the race-day use of furosemide (Salix).
Members of the Kentucky Horse Racing Commission staff outlined changes that have been put in place to prevent future mistakes in the administration of race-day Salix at the state's tracks.
Kentucky horsemen are losing patience with a new policy that requires regulatory veterinarians to administer furosemide on race day after mistakes have led to horses being scratched on consectutive race days at Churchill.
Trainers Todd Pletcher and Mark Casse took issue with the Breeders' Cup decision banning the anti-bleeding medication furosemide in this year's five juvenile races during the World Thoroughbred Championships.
Most Popular Stories
- Unique Bella Sidelined Due to Shin Issue
- Classic Empire to Arkansas Derby After Impressive Work
- Arrogate Last to First in Dubai World Cup
- Tepin Refuses to Work March 27 at Palm Meadows
- McCraken, Gunnevera Top Kentucky Derby Future Wager
- Steve Haskin's Derby Dozen - March 28, 2017
- Tapit Colt Tops Barretts Hips to Watch
- Arrogate and How We Define Greatness
- Hence Springs Upset in Sunland Derby
- Skychai Racing Purchases Interest in Fast and Accurate